Adiuvo Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.30 M
as on 08-12-2024
- Paid Up Capital ₹ 0.22 M
as on 08-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 181.83%
(FY 2022)
- Profit -2332669.12%
(FY 2022)
- Ebitda -1258.35%
(FY 2022)
- Net Worth -7.64%
(FY 2022)
- Total Assets -7.77%
(FY 2022)
About Adiuvo Diagnostics
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.30 M and a paid-up capital of Rs 0.22 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Adiuvo Diagnostics Private Limited India is Radhakrishnan Geethanjali as CEO. George Thomas, Radhakrishnan Geethanjali, and Balasubrahmanyam Pesala serve as directors at the Company.
- CIN/LLPIN
U74120AP2015PTC097966
- Company No.
097966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Nellore, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Adiuvo Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radhakrishnan Geethanjali  | Managing Director | 29-Dec-2015 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| George Thomas | Nominee Director | 30-Jan-2020 | Current |
| Balasubrahmanyam Pesala | Additional Director | 29-Nov-2024 | Current |
Financial Performance and Corporate Structure Insights of Adiuvo Diagnostics.
Adiuvo Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 181.83% increase. The company also saw a substantial fall in profitability, with a 2332669.12% decrease in profit. The company's net worth dipped by a decrease of 7.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adiuvo Diagnostics?
In 2022, Adiuvo Diagnostics had a promoter holding of 99.01% and a public holding of 0.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Teralumen Solutions Private LimitedActive 5 years 5 monthsGeorge Thomas and Balasubrahmanyam Pesala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adiuvo Diagnostics?
Adiuvo Diagnostics has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adiuvo Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adiuvo Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
